The results of model studies of oral zinc supplementation in type 1 and 2 diabetes mellitus in rats showed that it reduces insulin resistance, elevated insulin levels, and the cytotoxic effect of streptozotocin. The gene discussed is INS; the disease is Insulin resistance.